Molecular Mechanisms of Dementia, April 2019, Pages 73-112
Focussing on SDGs 8 (Decent Work and Economic Growth), 16 (Peace, Justice and Strong Institutions) and 17 (Partnerships for the Goals), Dr Alison Gardner, head of the Rights Lab’s Governance Programme, discusses the Slavery-Free Communities Programme’s work, highlighting promising practices in the context of Nottingham and the UK.
Health Policy, Volume 124, Issue 6, June 2020, Pages 581-590
In 2017, the UN adopted a global SDG indicator framework, calling for complementary national and regional indicators to be collected by member countries, while the UN Habitat developed an indicator action framework specifically for cities. This paper examined the extent to which using UN Sustainable Development Goal indicators framework will help cities evaluate their efforts to deliver sustainability and health outcomes. It identified inconsistencies between the two two frameworks. Many of the SDG indicators assessed outcomes, rather than the ‘upstream’ policies and interventions required to deliver outcomes on-the-ground. Conversely, the UN Habitat framework incorporated intervention indicators, but excluded health outcome indicators. We proposed a more comprehensive approach to benchmarking, monitoring and evaluating policies designed to achieve healthy and sustainable cities and assessing spatial inequities.
Despite the great potential of mobile data to support the delivery of the sustainable development agenda across sub-Saharan Africa, access to the data remains a great challenge due to real or perceived barriers. In order to address gaps in timely data that provide information on the SDGs, a multistakeholder workshop was held in Nairobi, Kenya, in February 2019, contributing to SDGs 9 and 17.
During the World Economic Forum in Davos, Márcia Balisciano, Corporate Responsibility Director at RELX Group, spoke about how women are advancing the 17 SDGs in a panel empowering women to advance the goals.
Alzheimer's Disease Theranostics, January 2019, Pages 7-12
This book chapter advances SDGs 3 and 17 by focusing primarily on the recent developments in Alzheimer's Disease diagnosis and their merits and demerits, including development of blood and cerebrospinal fluid–based biomarkers, imaging tools such as MRI, fMRI, and PET, proteomics, etc.
Advancing goal 17, this report seeks to inspire and guide companies, governments, cities and others involved in the implementation of Agenda 2030 to tap into the private capital markets and benefit from cheaper and more reliable capital to support the implementation of their SDG strategies. It introduces a roadmap for mainstream SDG bonds and corporate SDG finance to tap into the largest assets classes and respond to the specific financing challenges in emerging markets.
Investors, governments, and other stakeholders are increasingly demanding that companies demonstrate sustainable strategies aligned with the SDGs. A credible SDG strategy allows a company to clearly communicate its impact, facilitates easier access to the growing market for SDG financing, and connects investors with a pipeline of potential opportunities to address the SDG investment gap. This guide seeks to support companies looking to integrate the SDGs into their financial strategy and business model, contributing to SDGs 8, 12 and 17.
While the public sector and public finance will be core to the implementation of the SDGs, it is widely acknowledged that the private sector and capital markets must also play a key role. This report furthers SDGs 8, 12 and 17 by seeking to inspire major players in the investment value chain to build a market for mainstream SDG investments, with enough scale, liquidity and diversification to attract large institutional investors and finance a broad set of private- and public-sector activities in support of the SDGs.